Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “VHL Syndrome”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02859441
What this trial is testing

A Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination of the PDGF Antagonist E10030 and the VEGF Antagonist Ranibizumab

Who this might be right for
Von Hippel-Lindau Syndrome
National Eye Institute (NEI) 3
Not applicableEnrolling By InvitationNCT00102544
What this trial is testing

Use of Tracking Devices to Locate Abnormalities During Invasive Procedures

Who this might be right for
AdenocarcinomaProstate NeoplasmsProstate Cancer+2 more
National Institutes of Health Clinical Center (CC) 3,894
Not applicableActive Not RecruitingNCT06195150
What this trial is testing

Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaVHL Syndrome
IRCCS San Raffaele 3
Not applicableUnknownNCT03979833
What this trial is testing

Drivers of Hypoxia-induced Angiogenesis in Tumor Development

Who this might be right for
Von Hippel-Lindau Disease
University of Copenhagen 10
Not applicableActive Not RecruitingNCT07275099
What this trial is testing

Quality of Life, Psychological Impact, and Care-related Challenges in Patients Affected by Von Hippel-Lindau Syndrome.

Who this might be right for
VHL - Von Hippel-Lindau Syndrome
IRCCS Ospedale San Raffaele 200
Testing effectiveness (Phase 2)Ended earlyNCT01266070
What this trial is testing

TKI 258 in Von Hippel-Lindau Syndrome (VHL)

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00385333
What this trial is testing

Metabolic Mapping to Measure Retinal Metabolism

Who this might be right for
Macular DegenerationDiabetic RetinopathyHippel-Landau Disease+1 more
National Eye Institute (NEI) 28
Early research (Phase 1)Study completedNCT02108002
What this trial is testing

Effect of Vorinostat on Nervous System Hemangioblastomas in Von Hippel-Lindau Disease (Missense Mutation Only)

Who this might be right for
Von Hippel-Lindau Disease
National Institute of Neurological Disorders and Stroke (NINDS) 7
Not applicableLooking for participantsNCT05424016
What this trial is testing

Propranolol and Von Hippel-Lindau Disease

Who this might be right for
Hemangioblastoma of CNSVon Hippel-Lindau Disease
Assistance Publique - Hôpitaux de Paris 85
Early research (Phase 1)UnknownNCT05843305
What this trial is testing

BPI-452080 in Subjects With Solid Tumors

Who this might be right for
Solid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease
Betta Pharmaceuticals Co., Ltd. 87
Not applicableUnknownNCT06391879
What this trial is testing

Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell Carcinoma

Who this might be right for
VHL SyndromeRenal Cell Carcinoma
Peking University First Hospital 300
Not applicableUnknownNCT05534854
What this trial is testing

Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer Syndromes

Who this might be right for
Renal Tumor HistologyKidney CancerRenal Cell Carcinoma+11 more
RenJi Hospital 500
Large-scale testing (Phase 3)Looking for participantsNCT07405164
What this trial is testing

Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043)

Who this might be right for
Von Hippel-Lindau DiseaseMalignant Neoplasms
Merck Sharp & Dohme LLC 450
Early research (Phase 1)Study completedNCT00056199
What this trial is testing

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Hippel-Lindau Disease
National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT07167329
What this trial is testing

Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Who this might be right for
Von Hippel LindauVon Hippel Lindau DiseaseVon Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma+5 more
José Claudio Casali da Rocha 100
Not applicableActive Not RecruitingNCT05737602
What this trial is testing

Promoting Stress Management and Resilience Among Individuals With Von Hippel- Lindau Disease

Who this might be right for
Von Hippel-Lindau DiseaseGenetic Disorder
Massachusetts General Hospital 40
Testing effectiveness (Phase 2)Looking for participantsNCT04924075
What this trial is testing

Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

Who this might be right for
Pheochromocytoma/ParagangliomaPancreatic Neuroendocrine TumorVon Hippel-Lindau Disease+2 more
Merck Sharp & Dohme LLC
Testing effectiveness (Phase 2)Study completedNCT01436227
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome

Who this might be right for
Von Hippel-Lindau Syndrome
M.D. Anderson Cancer Center 32
Not applicableLooking for participantsNCT06523582
What this trial is testing

Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients

Who this might be right for
Neuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more
Universidad Nacional Autonoma de Mexico 750
Very early researchEnded earlyNCT01015300
What this trial is testing

Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

Who this might be right for
HemangioblastomasVon Hippel Lindau Disease
Dartmouth-Hitchcock Medical Center 1
Next Page
355